Dr.ย Sung-Sooย Yoon
M.D., M.S., Ph.D.
Professor of Internal Medicine & Haemato-Oncologist
corporate_fareSeoul National University Hospital, Seoul
Sung-Soo Yoon
M.D., M.S., Ph.D.
Prof. Sung-Soo Yoon is a senior Professor of Internal Medicine at Seoul National University Hospital and Seoul National University College of Medicine, one of South Korea's leading academic medical centres. His clinical and research work is centred on haematologic malignancies, with a sustained focus on multiple myeloma, lymphoma, and haematopoietic stem cell transplantation.
Prof. Yoon completed his M.D. at Seoul National University College of Medicine in 1984 and went on to earn an M.S. and Ph.D. from Seoul National University Graduate School in 1987 and 1996 respectively. Over four decades of academic and clinical practice, he has built an extensive publication record exceeding 530 research outputs, covering multiple myeloma treatment strategy, acute myeloid leukaemia, allogeneic and autologous stem cell transplantation, and cancer hematogenomics. He leads the Laboratory of Cancer Hematogenomics at the Seoul National University Cancer Research Institute, where his team conducts domestic and international collaborative research into the biology and treatment of haematologic malignancies. His research encompasses modern treatment approaches including proteasome inhibitor-based therapy, bispecific antibody treatment in Korean patients, and molecularly informed myeloma care.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert opinion from Prof. Yoon at Seoul National University Hospital.
Why Consider Prof. Sung-Soo Yoon?
Patients with complex blood cancers โ particularly multiple myeloma, lymphoma, and conditions requiring stem cell transplantation โ may benefit from Prof. Yoon's deep academic expertise and his access to multidisciplinary specialist teams at one of South Korea's most respected cancer hospitals.
Areas of Specialisation
Prof. Yoon's clinical focus spans the full range of haematologic malignancies, with particular depth in multiple myeloma, lymphoma, and haematopoietic stem cell transplantation.
Prof. Sung-Soo Yoon's practice covers the diagnosis, treatment, and research of blood cancers, drawing on more than four decades of clinical and academic work at Seoul National University Hospital.
Multiple Myeloma
Comprehensive myeloma care including risk stratification, treatment planning, and access to modern systemic approaches.
- arrow_rightPathology and biomarker-based risk stratification for newly diagnosed patients
- arrow_rightTreatment sequencing guidance based on disease stage and molecular profile
- arrow_rightProteasome inhibitor-based regimens including bortezomib and carfilzomib protocols
- arrow_rightBispecific antibody treatment in eligible myeloma patients
- arrow_rightResearch-informed treatment planning for relapsed or refractory myeloma
Lymphoma
Evaluation and management of lymphoid malignancies within a multidisciplinary academic hospital setting.
- arrow_rightAssessment and treatment planning for Hodgkin and non-Hodgkin lymphoma
- arrow_rightSystemic therapy for aggressive and indolent lymphoid malignancies
Haematopoietic Stem Cell Transplantation
Transplant-related evaluation and care as part of comprehensive haemato-oncology management.
- arrow_rightAutologous transplantation as part of myeloma treatment strategy
- arrow_rightPre-transplant evaluation and post-transplant monitoring
- arrow_rightAllogeneic transplantation for selected haematologic malignancies
- arrow_rightMultidisciplinary transplant team coordination
Procedures & Clinical Services
Clinical approaches and treatment services within Prof. Yoon's haemato-oncology practice
Prof. Yoon's clinical practice encompasses haematologic assessment, systemic cancer treatment, stem cell transplantation, and participation in clinical trials for blood cancers.
Haematologic Malignancy Assessment
DiagnosisComprehensive evaluation of blood cancers including pathology review, biomarker analysis, and staging.
Medical Haemato-Oncology Treatment
Medical OncologySystemic treatment planning and administration for haematologic malignancies.
Stem Cell Transplantation
TransplantAutologous and allogeneic haematopoietic stem cell transplantation as part of haematologic malignancy management.
Second Opinion & Complex Case Review
Second OpinionExpert second-opinion review for patients with multiple myeloma, lymphoma, or other haematologic malignancies.
Research & Publications
Peer-reviewed contributions in haematology, multiple myeloma, and blood cancer research
Prof. Yoon has an extensive publication record with over 530 research outputs spanning more than three decades, covering multiple myeloma, lymphoma, acute myeloid leukaemia, and haematopoietic stem cell transplantation. He leads the Laboratory of Cancer Hematogenomics at the SNU Cancer Research Institute.
Seoul National University's research portal lists over 530 research outputs for Prof. Yoon, with research activity from 1987 to 2026 across multiple myeloma, AML, lymphoma, and haematopoietic stem cell transplantation.
Education & Training
Prof. Yoon completed his full medical training at Seoul National University, earning his M.D. in 1984 followed by postgraduate research degrees in 1987 and 1996.
Clinical Experience
Prof. Yoon has spent his entire career at Seoul National University, building one of South Korea's most recognised academic haematology practices over more than four decades.
Languages & International
Prof. Yoon consults primarily in Korean. English-language consultation support or international correspondence has not been publicly confirmed; CancerFax recommends confirming language preferences directly with the hospital.
CancerFax can coordinate professional medical interpreter support for international patients, including English and other languages, when consulting at Seoul National University Hospital.
CancerFax can coordinate professional medical interpreter support for international patients where required.
How CancerFax Helps You Access Dr. Sung-Soo Yoon
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Sung-Soo Yoon's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Sung-Soo Yoon's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Sung-Soo Yoon before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Sung-Soo Yoon's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Sung-Soo Yoon's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Sung-Soo Yoon's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Sung-Soo Yoon
Prof. Sung-Soo Yoon is a Professor of Internal Medicine at Seoul National University Hospital and Seoul National University College of Medicine in Seoul, South Korea. He is a specialist in haematology and hemato-oncology, with particular expertise in multiple myeloma, lymphoma, and haematopoietic stem cell transplantation. He also leads the Laboratory of Cancer Hematogenomics at the SNU Cancer Research Institute.
Prof. Yoon's verified clinical and research focus includes multiple myeloma, lymphoma, acute myeloid leukaemia, and haematologic malignancies requiring haematopoietic stem cell transplantation. Multiple myeloma and lymphoma are his primary areas of practice and academic output.
Yes. Multiple myeloma is one of Prof. Yoon's primary disease focus areas and is a central theme across his published research. His work covers newly diagnosed myeloma, risk stratification, treatment sequencing, proteasome inhibitor-based regimens, and emerging approaches including bispecific antibody therapy in Korean patients.
Yes. Haematopoietic stem cell transplantation is listed among his clinical and research focus areas. His publication record includes work on both allogeneic and autologous stem cell transplantation, and he practices within the transplant-capable environment of Seoul National University Hospital.
Seoul National University Hospital provides international patient services, including appointment support and language resources on its global website. CancerFax can coordinate medical-report review and consultation support for international patients, subject to hospital availability and case acceptance. Appointment availability with Prof. Yoon should be confirmed with the hospital before travel.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case, and coordinate the next steps with Seoul National University Hospital, subject to availability. For a second opinion, include pathology reports, imaging, treatment history, and any molecular or biomarker results.
Connect with Sung-Soo Yoon Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.